Source: Annual Congress 2002 - COPD - general -1
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kythreotis, N. Lolis, E. Ablianitis, P. Bakakos, A. Kokkini, E. Anastasakou, A. Rasidakis (Athens, Greece). Leptin and inflammatory cytokines during COPD exacerbation. Eur Respir J 2002; 20: Suppl. 38, 1626

Member's Comments

No comment yet.

Related content which might interest you: Leptin during COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Procalcitonin and inflammatory cytokines in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 115s Year: 2002 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 IL-18 in infectious exacerbations of COPD Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Proinflammatory cytokines in induced sputum and COPD phenotype Source: Annual Congress 2011 - COPD: human studies Year: 2011 Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – COPD management Year: 2017 Inflammatory cytokines of patients with peripheral arterial disease and COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 M2 chemokines during acute exacerbations of IPF Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 Interleukin-33 and Th2 cytokines correlate in acute asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Investigation of alarmins, interleukin (IL-)23 and IL-36 sputum levels in chronic airway obstructive diseases. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019